Award
Purchase Order #75F40126P00203
Purchase Order for Genomic Sequencing Systems Awarded to Illumina, Inc.
Buyer
Food and Drug Administration
Award Amount
$574,784.84
Ceiling
$871,490.84
Awarded
September 17, 2026
Period of Performance
Sep 17, 2026 – Nov 16, 2027
Identifier
75F40126P00203
NAICS
334516
This contract award represents a purchase order for genomic sequencing equipment. The recipient, Illumina, Inc., is a leading biotechnology company specializing in genetic sequencing technologies, providing advanced tools for genomic research. The contract procures five MiSeq i100 Plus genomic sequencing systems, which are instrumental for genetic analysis and research activities. This procurement is significant as it equips the awarding agency with cutting-edge sequencing capabilities essential for advancing scientific and medical research. The scope includes delivery and provision of five advanced sequencing systems to the location in Laurel, Maryland. Awarded through a competitive acquisition process, this contract reflects the agency's commitment to leveraging high-quality sequencing technology. The agreement spans a multi-year period, with performance scheduled to commence and conclude between specified years, with potential extension options. This award enhances the agency’s genomic research infrastructure, supporting ongoing scientific initiatives with reliable, state-of-the-art equipment.
Description
"EO 14398" FIVE (5) GENOMIC SEQUENCING SYSTEMS MISEQ I100 PLUS SYSTEMS